'Pharma cos must upgrade production facilities to enter remunerative markets'

摘要

The objective of changes incorporated in the revised Schedule 'M' guidelines, substituting the Schedule 'M' of the Drugs and Cosmetics Rules, 1945, is to achieve uniform standardisation, upgradatio of quality of drugs produced with a view to enhancing the credibility of pharma industry, according to industry platyers.